FDAnews Drug Daily Bulletin

Aug. 2, 2010 | Vol. 7 No. 149

Teva Launches Generic Version of Antidepressant Effexor XR

Teva has begun shipping its generic version of Wyeth’s antidepressant Effexor XR after the FDA approved the company’s ANDA, and the world’s largest generic-drug maker also was awarded 180-day marketing exclusivity. Wyeth, now part of Pfizer, has been embroiled in patent litigation with many companies seeking to market Effexor XR (venlafaxine extended-release) generics. Teva is the first company to launch under a 2006 agreement with Wyeth.
Generic Line

Register Now
Print This Page
Email This Article
RSS
Archives

Genentech Breast Cancer Drug Denied Accelerated Approval FDA Grants GSK, HGS Lupus Drug Priority Review, Sets PDUFA Date Genentech Breast Cancer Drug Denied Accelerated Approval MedImmune Asked to Conduct Another Trial for RSV Drug

Home
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.